DATE: May 11, 2012 TO: Medicis Pharmaceutical Corporation 7720 North Dobson Road Scottsdale, Arizona 85256 ATTENTION: Richard D. Peterson FACSIMILE: (480) 291-8847 FROM: Deutsche Bank AG, London Branch SUBJECT: Additional Warrant Transaction REFERENCE...Additional Warrant Transaction • May 16th, 2012 • Medicis Pharmaceutical Corp • Pharmaceutical preparations
Wells Fargo Bank, National Association New York, NY 10152 Attn: Structuring Services Group Email: CorporateDerivativeNotifications@wellsfargo.com DATE: December 9, 2016 TO: Teradyne, Inc. North Reading, MA 01864 ATTENTION: Michael Callahan EMAIL:...Additional Warrant Transaction • December 12th, 2016 • Teradyne, Inc • Instruments for meas & testing of electricity & elec signals • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between Wells Fargo Bank, National Association (“Dealer”) and Teradyne, Inc. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.
TO: DealerTrack Holdings, Inc. ATTENTION: President and Chief Executive Officer TELEPHONE: 516-734-3700 FACSIMILE: 516-300-8003 FROM: WELLS FARGO SECURITIES, LLC (“Agent”) solely as agent of Wells Fargo Bank, National Association (“Dealer”) New York,...Additional Warrant Transaction • March 6th, 2012 • DealerTrack Holdings, Inc. • Services-computer integrated systems design
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between Wells Fargo Bank, National Association (“Dealer”), through its agent Wells Fargo Securities, LLC (the “Agent”), and DealerTrack Holdings, Inc. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Master Agreement specified below.
